Assignee
CS PHARMATECH LTD
KY·1 granted patent·1 pending application·0 citations·filing 2017–2018
Top patents by PatentIndex Score
2 records- 0137US10435388B2Selective inhibitors of clinically important mutants of the EGFR tyrosine kinaseCS PHARMATECH LTD·Filed 2017·Granted Oct 8, 2019·0 cites·24 claims
- 0236US2020131176A1Selective inhibitors of clinically important mutants of the egfr tyrosine kinaseCS PHARMATECH LTD·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →